Biogen (BIIB) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$3.8 billion.
- Biogen's Enterprise Value fell 6066.11% to -$3.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.8 billion, marking a year-over-year decrease of 6066.11%. This contributed to the annual value of -$3.8 billion for FY2025, which is 6066.11% down from last year.
- Per Biogen's latest filing, its Enterprise Value stood at -$3.8 billion for Q4 2025, which was down 6066.11% from -$4.0 billion recorded in Q3 2025.
- Biogen's 5-year Enterprise Value high stood at -$1.0 billion for Q4 2023, and its period low was -$6.1 billion during Q2 2023.
- In the last 5 years, Biogen's Enterprise Value had a median value of -$2.7 billion in 2025 and averaged -$3.2 billion.
- As far as peak fluctuations go, Biogen's Enterprise Value surged by 7872.85% in 2024, and later tumbled by 14183.73% in 2025.
- Quarter analysis of 5 years shows Biogen's Enterprise Value stood at -$3.7 billion in 2021, then tumbled by 31.11% to -$4.9 billion in 2022, then surged by 78.58% to -$1.0 billion in 2023, then crashed by 126.21% to -$2.4 billion in 2024, then plummeted by 60.66% to -$3.8 billion in 2025.
- Its last three reported values are -$3.8 billion in Q4 2025, -$4.0 billion for Q3 2025, and -$2.8 billion during Q2 2025.